SS-31 Peptide Research
SS-31 is a mitochondria-targeted peptide studied for bioenergetic support and oxidative-stress reduction.
mitochondrial peptide
Early Clinical
research maturity
Overview
SS-31, also known in some development contexts as elamipretide, is a mitochondria-targeted peptide investigated for mitochondrial protection, oxidative-stress reduction, and bioenergetic improvement in tissues such as heart and skeletal muscle.
Comparisons
Related stacks
Mitochondrial Defense Stack
Longevity Stack
Mechanism
It is proposed to stabilize mitochondrial membranes and reduce reactive oxygen species, thereby improving ATP production and cellular energy efficiency under stress conditions.
Clinical interest
Clinical interest centers on mitochondrial health, aging biology, muscle energetics, and recovery in high-demand tissues. It is stronger scientifically than many fringe peptides, but still should be discussed with translational caution.
Research summary
The cited literature shows consistent preclinical support across cardiac, ischemia-reperfusion, and skeletal-muscle models. The scientific case is stronger than many experimental peptides, but it still should not be equated with approved standard therapy.
Safety considerations
The main communication risk is overstating promising mitochondrial findings as broad clinical proof. Human relevance, indication-specific benefit, and real-world dosing remain important open questions.
Key information
Research stage
Early Clinical
Evidence rating
Moderate
Search intent
informational
Last review
Mar 13, 2026
Featured studies
(
5
)
Frequently asked questions
What is SS-31?
SS-31 is a mitochondria-targeted peptide studied for reducing oxidative stress and improving cellular energy production.
Is SS-31 an approved therapy?
No. It remains investigational despite a stronger scientific basis than many gray-market mitochondrial compounds.